Adaptimmune Therapeutics plc (ADAP) ADS

Sell:$0.90Buy:$0.90$0.10 (9.84%)

NASDAQ:0.52%
Market closed | Prices delayed by at least 15 minutes
Sell:$0.90
Buy:$0.90
Change:$0.10 (9.84%)
Market closed | Prices delayed by at least 15 minutes
Sell:$0.90
Buy:$0.90
Change:$0.10 (9.84%)
Market closed | Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
17 January 2024
Adrian (Ad) RawcliffeCEO
Sell
Tax related
30,080$0.67$20,243.8444,848
17 January 2024
William C Jr (Bill) BertrandCOO
Sell
Tax related
13,599$0.67$9,152.1320,201
17 January 2024
Elliot NorryOther Level A
Sell
Tax related
12,967$0.67$8,726.7919,257
17 January 2024
John LungerChief Level Officer
Sell
Tax related
12,805$0.67$8,617.7719,015
17 January 2024
John LungerChief Level Officer
Sell
Tax related
5,309$0.67$3,572.967,785
17 January 2024
Elliot NorryOther Level A
Sell
Tax related
5,309$0.67$3,572.967,785
17 January 2024
William C Jr (Bill) BertrandCOO
Sell
Tax related
5,309$0.67$3,572.967,785
16 January 2024
Adrian (Ad) RawcliffeCEO
Sell
Tax related
9,304$0.79$7,350.1614,104
16 January 2024
John LungerChief Level Officer
Sell
Tax related
4,681$0.79$3,697.997,023
16 January 2024
William C Jr (Bill) BertrandCOO
Sell
Tax related
4,681$0.79$3,697.997,023

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
10 July 2023
Garry E MenzelDirector
Sell
Tax related
47,702$0.91$43,446.9875,056
17 January 2024
Adrian (Ad) RawcliffeCEO
Sell
Tax related
30,080$0.67$20,243.8444,848
12 January 2024
Adrian (Ad) RawcliffeCEO
Sell
Tax related
17,257$0.85$14,739.2026,388
11 January 2024
Adrian (Ad) RawcliffeCEO
Sell
Tax related
11,945$0.84$9,994.3818,395
17 January 2024
William C Jr (Bill) BertrandCOO
Sell
Tax related
13,599$0.67$9,152.1320,201

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.